Spectral AI to Showcase Burn Wound AI Tech at ACS Clinical Congress…

Event summary

Spectral AI will present at ACS Clinical Congress 2026 (Sept. 26-29) on AI and multi-spectral imaging for burn wound assessment.
Presentation led by James H. Holmes IV, MD, Director of the Burn Center at Atrium Health Wake Forest Baptist Medical Center.
DeepView System received FDA De Novo Classification in May 2026 and UKCA authorization in February 2024.
System processes burn wound data in 20-25 seconds using a database of over 340 billion pixels of burn wound image data.

The big picture

Spectral AI's presentation at ACS Clinical Congress 2026 underscores the growing intersection of AI and surgical innovation. The company aims to transition from niche burn centers to broader surgical care, a strategic shift that could significantly expand its market reach. With FDA and UKCA clearances already secured, the focus now shifts to commercialization and adoption rates in diverse healthcare settings.

What we're watching

Market Expansion: How Spectral AI will leverage ACS Clinical Congress to expand DeepView adoption beyond specialized burn centers.
Regulatory Compliance: Whether the company can sustain its regulatory momentum with additional approvals in key markets.
Commercialization Pace: The pace at which Spectral AI can integrate DeepView into broader surgical and acute-care settings.